JOHNSON MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C82031 | LEICESTER, LE5 1BL
Showing results 101-150 of 656
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Clobetasone butyrate | 511 | 25.0K | £2.4K | +150.4% ▲ |
| Warfarin sodium | 503 | 42.5K | £1.4K | +6.7% ▲ |
| Pantoprazole | 497 | 16.6K | £747 | +80.8% ▲ |
| Hydroxychloroquine sulfate | 482 | 23.7K | £1.2K | +148.9% ▲ |
| Levetiracetam | 477 | 62.6K | £3.3K | +4.2% ▲ |
| Insulin glargine | 468 | 1,898 | £16.8K | +64.8% ▲ |
| Isophane insulin | 454 | 2,287 | £10.0K | +330.0% ▲ |
| Morphine sulfate | 425 | 64.0K | £2.3K | -35.2% ▼ |
| Telmisartan | 424 | 13.2K | £2.4K | +631.4% ▲ |
| Calcipotriol | 420 | 45.5K | £21.0K | +146.7% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 418 | 14.5K | £1.4K | +173.7% ▲ |
| Diazepam | 411 | 11.1K | £252 | -17.5% ▼ |
| Olanzapine | 411 | 10.8K | £3.4K | +10.9% ▲ |
| Atenolol | 406 | 13.6K | £298 | -32.7% ▼ |
| Aripiprazole | 403 | 12.5K | £2.6K | +58.4% ▲ |
| Mebeverine hydrochloride | 395 | 31.8K | £1.2K | +27.2% ▲ |
| Thiamine hydrochloride | 395 | 25.3K | £624 | -25.1% ▼ |
| 390 | 413 | £2.3K | +65.1% ▲ | |
| Hypromellose | 388 | 4,600 | £1.3K | +192.8% ▲ |
| Tirzepatide | 381 | 406 | £39.2K | +96.2% ▲ |
| Sacubitril/valsartan | 375 | 20.6K | £33.8K | +56.6% ▲ |
| Methotrexate | 369 | 9,488 | £607 | +13.4% ▲ |
| Diphtheria | 365 | 365 | £2.6K | +446.9% ▲ |
| Quetiapine | 364 | 15.4K | £6.4K | -41.5% ▼ |
| Carbamazepine | 361 | 50.7K | £2.5K | +21.6% ▲ |
| Sodium valproate | 358 | 79.6K | £5.0K | +12.6% ▲ |
| Alfacalcidol | 356 | 12.5K | £1.7K | +187.8% ▲ |
| Pravastatin sodium | 354 | 10.1K | £475 | +9.0% ▲ |
| 352 | 352 | £15.5K | +13.3% ▲ | |
| Famotidine | 349 | 11.5K | £6.6K | -28.5% ▼ |
| Mirabegron | 343 | 10.5K | £9.6K | -14.6% ▼ |
| Sumatriptan succinate | 337 | 2,495 | £542 | -4.8% ▼ |
| Carbocisteine | 329 | 37.9K | £1.7K | -38.4% ▼ |
| Clobetasol propionate | 329 | 22.5K | £1.7K | +141.1% ▲ |
| Bumetanide | 322 | 26.2K | £2.6K | +18.2% ▲ |
| Mesalazine (Systemic) | 319 | 28.7K | £15.7K | +33.2% ▲ |
| Nortriptyline | 318 | 18.9K | £1.9K | +118.6% ▲ |
| Methylphenidate hydrochloride | 318 | 10.9K | £8.1K | +23.1% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 311 | 23.4K | £1.3K | +73.1% ▲ |
| Melatonin | 309 | 22.0K | £12.2K | -7.1% ▼ |
| Bisacodyl | 307 | 16.4K | £937 | +134.2% ▲ |
| Cyclizine hydrochloride | 305 | 12.1K | £475 | +89.1% ▲ |
| Insulin degludec | 305 | 1,442 | £16.0K | +177.5% ▲ |
| Estradiol | 305 | 23.0K | £4.5K | -62.8% ▼ |
| Hepatitis A | 304 | 304 | £5.5K | +300.4% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 300 | 301 | £4.2K | +164.5% ▲ |
| Nifedipine | 295 | 13.6K | £2.5K | +57.4% ▲ |
| Rivaroxaban | 295 | 9,063 | £6.0K | -51.8% ▼ |
| Felodipine | 287 | 8,834 | £1.3K | -51.7% ▼ |
| Procyclidine hydrochloride | 287 | 11.7K | £590 | +102.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.